Midas AI Signs Contract to Supply 3 Billion KRW Worth of COVID-19 Diagnostic and Specimen Collection Kits to Japan
[Asia Economy Reporter Hyunseok Yoo] Midas AI has signed its first supply contract since entering the business related to the novel coronavirus infection (COVID-19).
On the 6th, Midas AI announced that it signed a contract to supply COVID-19 diagnostic kits and specimen collection kits with Japan's JFC Co. Ltd. The supply contract is worth a total of 3 billion KRW and includes a minimum order quantity (MOQ).
In September, Midas AI entered the COVID-19 related product business by signing an overseas regional distribution rights contract with Philosis, which developed COVID-19 diagnostic kits and specimen collection kits.
The items to be supplied this time include ▲point-of-care testing devices (POCT) ▲antigen and antibody rapid diagnostic kits ▲specimen collection transport media (UTM), all developed by Philosis.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- The Unexpected Story of an American Man Who Won the Lottery 18 Times in 29 Years: "My Real Luck Is My Wife"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
A company official stated, “We recently received global distribution rights from Philosis to expand the sales regions of the diagnostic kits,” adding, “We will expand sales of the diagnostic kits beyond the initial licensed regions of Brazil and Africa to all overseas regions.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
